Original articleOptic gliomas in neurofibromatosis type 1: Role of visual evoked potentials
References (30)
- et al.
Von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata
Ophthalmology
(1984) - et al.
Optic gliomas in children with neurofibromatosis type 1
J Pediatr
(1989) - et al.
Optic glioma: Long term follow up of 85 histopathologically verified cases
Ophthalmology
(1982) - et al.
Brainstem auditory, pattern-reversal visual, and short latency somatosensory evoked potentials: Latencies in relation to age, sex and brain and body size
Electroencephalogr Clin Neurophysiol
(1983) - et al.
Von Recklinghausen neurofibromatosis: A clinical and population study in Southeast Wales
Brain
(1988) Recent developments in the diagnosis and management of neurofibromatosis
Arch Dis Child
(1989)- et al.
Optic gliomas in neurofibromatosis 1
Dev Med Child Neurol
(1990) Type 1 neurofibromatosis and the pediatric patient
Curr Probl Pediatr
(1992)- et al.
Optic gliomas in childhood: Natural history and rationale for conservative management
Br J Ophthalmol
(1969) - et al.
Visual morbidity and chiasmal glioma
Arch Ophthalmol
(1971)
Gliomas of the optic nerve and chiasm: Outcome by patients' age, tumour site and treatment
J Neurosurg
Optic gliomas. A reanalysis of the University of California experience
Cancer
Optic nerve glioma and the management of optic nerve tumours in the young
Br J Ophthalmol
Tumour spread in unilateral optic glioma
Neurofibromatosis
Chiasmal gliomas: Appearance and long term changes demonstrated by computerised tomography
J Neurosurg
Cited by (56)
Monitoring of optic nerve function in Neurofibromatosis 2 children with optic nerve sheath meningiomas using multifocal visual evoked potentials
2018, Journal of Clinical NeuroscienceCitation Excerpt :Thus our search for a new diagnostic tool, for the safe, objective, routine monitoring of ONSM in NF2 patients. Conventional visual evoked potentials (VEP) methods have been shown as sensitive tools in the assessment of optic nerve function of optic gliomas in NF1 [14,15] while mfVEP has been used in the assessment of two cases of paediatric optic nerve gliomas [16]. We hope to find a sensitive test in children without the risks of MRI, hence our selection to study mfVEP.
Visual Loss: Disorders of the Chiasm
2018, Liu, Volpe, and Galetta's Neuro-Ophthalmology: Diagnosis and ManagementLongitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas
2012, OphthalmologyCitation Excerpt :Visual acuities were converted to logarithm of the minimum angle of resolution (logMAR) units and then corrected for age (logMAR difference from the average of age-matched controls). Based on long-term variation in the patients with stable tumors and reported patients with NF1 and no glioma,25,26 an abnormal visual acuity criterion of 0.25 logMAR was selected. Formal field testing was attempted before initial treatment in children 6 years of age or older.
Visual Evoked Potentials in Infants and Children
2012, Aminoff's Electrodiagnosis in Clinical NeurologyElectrophysiological findings in neurofibromatosis type 1
2011, Journal of the Neurological SciencesOptical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas
2010, Journal of AAPOSCitation Excerpt :Although there can be variability in cooperation among children who are younger than 6 years of age, reliable OCT has been obtained in children as young as 3 years of age in the normative study.13 Several groups have evaluated VEP in the detection of OPGs, with sensitivity to be between 67% and 93% and specificity to be between 60% and 87%.28-30 Although VEP testing represents a noninvasive and physiologic method of measuring abnormal visual function, even in the absence of visual acuity change, it is reliant on experienced electrophysiologists who are not widely available.28,29